120 related articles for article (PubMed ID: 29374916)
21. The impact of admission red cell distribution width on long-term cardiovascular events after primary percutaneous intervention: A four-year prospective study.
Isik T; Kurt M; Tanboga IH; Ayhan E; Gunaydin ZY; Kaya A; Uyarel H
Cardiol J; 2016; 23(3):281-8. PubMed ID: 26711461
[TBL] [Abstract][Full Text] [Related]
22. Coronary severity score and C-reactive protein predict major adverse cardiovascular events in patients with stable coronary artery disease (from the Taichung CAD study).
Pan HC; Sheu WH; Lee WJ; Lee WL; Liao YC; Wang KY; Lee IT; Wang JS; Liang KW
Clin Chim Acta; 2015 May; 445():93-100. PubMed ID: 25818243
[TBL] [Abstract][Full Text] [Related]
23. Is there a relationship between epicardial adipose tissue, inflammatory markers and prognosis in COVID-19 in patients under 65 years?
Emekli E; Türkkanı MH; S Ballı S
Biomark Med; 2022 Aug; 16(12):925-933. PubMed ID: 35833879
[No Abstract] [Full Text] [Related]
24. Systemic inflammation in patients with chronic obstructive pulmonary disease undergoing percutaneous coronary intervention.
Zhang XL; Chi YH; Wang le F; Wang HS; Lin XM
Respirology; 2014 Jul; 19(5):723-9. PubMed ID: 24750361
[TBL] [Abstract][Full Text] [Related]
25. Clinical Significance of Cys-C and hs-CRP in Coronary Heart Disease Patients Undergoing Percutaneous Coronary Intervention.
Tan Z; Li L; Ma Y; Geng X
Braz J Cardiovasc Surg; 2019; 34(1):17-21. PubMed ID: 30810669
[TBL] [Abstract][Full Text] [Related]
26. Epicardial adipose tissue and cardiovascular outcome in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Tscharre M; Hauser C; Rohla M; Freynhofer MK; Wojta J; Huber K; Weiss TW
Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):750-752. PubMed ID: 27864479
[TBL] [Abstract][Full Text] [Related]
27. Influence of technical parameters on epicardial fat volume quantification at cardiac CT.
Bucher AM; Joseph Schoepf U; Krazinski AW; Silverman J; Spearman JV; De Cecco CN; Meinel FG; Vogl TJ; Geyer LL
Eur J Radiol; 2015 Jun; 84(6):1062-7. PubMed ID: 25843418
[TBL] [Abstract][Full Text] [Related]
28. Impact of adipose tissue composition on cardiovascular risk assessment in patients with stable coronary artery disease.
Kunimura A; Ishii H; Uetani T; Harada K; Hirayama K; Harata S; Shibata Y; Kawashima K; Shimbo Y; Takayama Y; Tatami Y; Kawamiya T; Osugi N; Ota T; Yamamoto D; Okumura N; Suzuki S; Amano T; Murohara T
Atherosclerosis; 2016 Aug; 251():206-212. PubMed ID: 27372206
[TBL] [Abstract][Full Text] [Related]
29. High sensitivity C-reactive protein to prealbumin ratio measurement as a marker of the prognosis in acute coronary syndrome.
Wang W; Ren D; Wang CS; Li T; Yao HC
Sci Rep; 2019 Aug; 9(1):11583. PubMed ID: 31399624
[TBL] [Abstract][Full Text] [Related]
30. [The predictive value of plasma cystatin C for non-ST-elevation acute coronary syndrome treated with percutaneous coronary intervention].
Yan S; Zhang X; Tian X; Li J; Zhuang L; Zhang X; Jiang Y
Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(1):10-3. PubMed ID: 24721298
[TBL] [Abstract][Full Text] [Related]
31. [Association between high-sensitivity C-reactive protein and contrast-induced nephropathy after primary percutaneous coronary intervention].
He YT; Tan N; Liu YH; Chen SQ; Liu Y; Huang SJ; Yang DH; Ye P; Ran P
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 May; 41(5):394-8. PubMed ID: 24021122
[TBL] [Abstract][Full Text] [Related]
32. Four-year clinical outcome in asymptomatic patients undergoing coronary computed tomography angiography.
Zhang KY; Gai LY; Gai JJ; He B; Guan ZW
Chin Med J (Engl); 2013; 126(9):1630-5. PubMed ID: 23652041
[TBL] [Abstract][Full Text] [Related]
33. Adverse events following percutaneous and surgical coronary revascularisation: Analysis of non-MACE outcomes in the Stent or Surgery (SoS) Trial.
Roberts EB; Perry R; Booth J; Sigwart U; Stables RH
Int J Cardiol; 2016 Jan; 202():7-12. PubMed ID: 26372883
[TBL] [Abstract][Full Text] [Related]
34. [Effect of intensive pretreatment with atorvastatin calcium on outcomes of percutaneous coronary intervention in elderly patients with coronary heart disease].
Guo X; Huang X; Wang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Feb; 35(2):295-300. PubMed ID: 25736134
[TBL] [Abstract][Full Text] [Related]
35. Value of peri-procedural B-type natriuretic peptide levels in predicting cardiac events after elective percutaneous coronary intervention.
Yildirir A; Acikel S; Ertan C; Aydinalp A; Ozin B; Muderrisoglu H
Acta Cardiol; 2008 Feb; 63(1):47-52. PubMed ID: 18372580
[TBL] [Abstract][Full Text] [Related]
36. Serum VEGF Predicts Worse Clinical Outcome of Patients with Coronary Heart Disease After Percutaneous Coronary Intervention Therapy.
Han X; Liu L; Niu J; Yang J; Zhang Z; Zhang Z
Med Sci Monit; 2015 Oct; 21():3247-51. PubMed ID: 26501555
[TBL] [Abstract][Full Text] [Related]
37. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in female patients with non-ST-segment elevation acute coronary syndrome.
Gao Y; Jia ZM; Sun YJ; Zhang ZH; Ren LN; Qi GX
Chin Med J (Engl); 2012 Jul; 125(13):2250-4. PubMed ID: 22882843
[TBL] [Abstract][Full Text] [Related]
38. Independent and Combined Effects of Serum Albumin and C-Reactive Protein on Long-Term Outcomes of Patients Undergoing Percutaneous Coronary Intervention.
Wada H; Dohi T; Miyauchi K; Doi S; Naito R; Konishi H; Tsuboi S; Ogita M; Kasai T; Okazaki S; Isoda K; Suwa S; Daida H
Circ J; 2017 Aug; 81(9):1293-1300. PubMed ID: 28428450
[TBL] [Abstract][Full Text] [Related]
39. High sensitive C-reactive protein and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention.
Shacham Y; Leshem-Rubinow E; Steinvil A; Keren G; Roth A; Arbel Y
Clin Exp Nephrol; 2015 Oct; 19(5):838-43. PubMed ID: 25492251
[TBL] [Abstract][Full Text] [Related]
40. Association of plasma apolipoprotein CIII, high sensitivity C-reactive protein and tumor necrosis factor-α contributes to the clinical features of coronary heart disease in Li and Han ethnic groups in China.
Chen L; Sun M; Liu H; Ma L; Wang T; Li P; Lin M; Lin H; Chang P; Liu Y
Lipids Health Dis; 2018 Jul; 17(1):176. PubMed ID: 30053815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
